Grown Rogue Reports Third Quarter 2026 Results

Grown Rogue International Inc. (GRUSF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Grown Rogue Reports Third Quarter 2026 Results Steady Execution Across Existing and New Markets; 2026 and 2027 Guidance and Growth Targets Maintained MEDFORD, Ore., Nov. 12, 2026 /CNW/ - Grown Rogue International Inc. ("Grown Rogue," "we," "us," "our," or the "Compan

Event · Earnings
Also in this documentGuidance · reaffirm · $38M–$41M

Facts are quoted from the filing text and checked against it.

Original reporting
Published Nov 12, 2026, 10:42 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 11:02 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$GRUSF
Bearish
medium confidence
Mentioned
$GRUSF
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$GRUSFBearishLow
01

Why it matters

The earnings release provides fresh financial data and guidance reaffirmation, offering traders a basis for short‑term positioning.

02

Market read

The filing delivers primary earnings information for a micro‑cap cannabis firm, affecting its stock and potentially related small‑cap cannabis peers.

03

What to watch

Potential upside from new market entries in Minnesota, New York, and Illinois, and the $5M acquisition cost may be a one-time hit.

Relevance 7/10Novelty 6/10Timing: after-market filing

Background

Grown Rogue is a flower-forward cannabis company reporting its Q3 2026 results via an SEC Form 8‑K, including operational updates and guidance.

Company-level read

Ticker impact

$GRUSFBearishMedium confidence
Context

Grown Rogue International Inc. filed its unaudited Q3 2026 results, reporting $11.0M revenue and a $8.9M net loss while reaffirming its 2026-2027 guidance.

Expected impact

likely pressure as market prices in the net loss and reaffirmed guidance

Evidence & confidence

Revenue rose 29% YoY, yet GAAP net loss expanded to $8.9M and a $5M acquisition loss was disclosed; unchanged guidance does not offset the loss perception.

Market effects

Highlights continued growth in the U.S. cannabis sector but underscores profitability challenges.

May influence investor sentiment toward other small-cap cannabis stocks in North America.

Limited to niche cannabis market; no broader macro impact.

Counterpoint

The reaffirmed guidance and expanding market presence could be seen as a long-term upside catalyst despite short-term loss.

Key entities

  • Grown Rogue International Inc.

    Cannabis producer reporting Q3 results and reaffirming guidance.

  • Obie Strickler

    CEO providing commentary on performance and market expansion.

Related articles

$GRUSFMed

Grown Rogue Reports Second Quarter 2026 Results

Grown Rogue International Inc. (GRUSF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Grown Rogue Reports Second Quarter 2026 Results Results and KPIs Highlight Continued Execution Against Growth Plans; 2026 and 2027 Guidance Increased MEDFORD, Ore., Aug. 4, 2026 /CNW/ - Grown Rogue International Inc. ("Grown Rogue," "we," "us," "our," or the "Company

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.

$YTRAMed

Yatra Online Inc (YTRA) (Q2 2027) Earnings Call Highlights: Air and Corporate Travel

Yatra Online (YTRA) reported Q2 2027 revenue from operations down 39% YoY to INR2,136M (~$22M) due to lower MICE volumes. Gross margin stayed flat at INR1,255M (~$13M). Adjusted EBITDA swung to negative INR32M (~negative $0.3M). CEO Gupta noted MICE recovery signs, TravelPro and Recap initiatives progress, and AI efficiency gains. Standalone hotels grew 20% YoY. H1 FY27 revenue declined 28% YoY to INR4,015M (~$42M).